#ExistInterpData>Refer to report.
See Compliance Statement B: www.aruplab.com/CS
||This assay is designed for individuals with a confirmed diagnosis of CLL, and for these individuals testing will include sequencing. All other diagnoses will terminate after amplification and will not have the sequencing component.
||IgVH Somatic Hypermutation (IgVH Mutation Analysis by Sequencing)